Earnings Feed
Start Free
PHIBRO ANIMAL HEALTH CORP·4

May 7, 7:34 PM ET

BENDHEIM JACK 4

Research Summary

AI-generated summary

Updated

Phibro (PAHC) 10% Owner/Director Jack Bendheim Sells Shares

What Happened

  • Jack Bendheim, a 10% owner and director of Phibro Animal Health Corp (PAHC), reported multiple open‑market sales (all "S" = sale) totaling 18,608 shares for approximately $1,016,228. The trades occurred May 5–7, 2026 at reported weighted average prices of $55.73, $56.37, $57.18, $58.13, $47.59, $48.31 and $49.19 per share across the individual lots. These were disposals (sales), which are typically routine liquidity events rather than affirmative bullish signals.

Key Details

  • Dates and reported lots (shares @ weighted avg. price):
    • 2026-05-05: 6,264 @ $55.73 and 776 @ $56.37 (combined 7,040 shares, ~$392,810)
    • 2026-05-06: 5,634 @ $57.18 and 1,406 @ $58.13 (combined 7,040 shares, ~$403,850)
    • 2026-05-07: 1,350 @ $47.59, 1,149 @ $48.31, 2,029 @ $49.19 (combined 4,528 shares, ~$219,568)
  • Total sold: 18,608 shares for about $1.02M. Price ranges across the multiple executions are disclosed in footnotes (roughly $47.00–$58.31 depending on lot).
  • Holdings after the transactions: not specified in the provided excerpt. The filing notes some securities are directly held by Jack Bendheim and some held by BFI Co., LLC (see footnotes).
  • Notable footnotes: sales were effected pursuant to a Rule 10b5‑1 trading plan adopted by BFI Co., LLC on Dec 11, 2025 (F1). The filing also clarifies that certain securities are directly held by BFI (F3) while others are directly held by Jack Bendheim (F10); Bendheim exercises voting/dispositive power over BFI but disclaims beneficial ownership except to the extent of his pecuniary interest. Weighted‑average price ranges and multiple execution details are provided in footnotes F2–F9.
  • Timeliness: Report filed 2026‑05‑07 covering trades on May 5–7, 2026; this filing appears timely under Form 4 reporting rules.

Context

  • These were open‑market sales under a pre‑set 10b5‑1 plan, a common mechanism insiders use to sell shares on a scheduled basis. As a 10% owner and director, Bendheim’s trades include securities held by an affiliated entity (BFI) — such filings can reflect institutional or pre‑planned liquidity rather than a personal, discretionary market view.